Xanax sourced to West Virginia-based company recalled nationwide. What you need to know
A specific portion of the drug Xanax, commonly prescribed to treat mental health conditions including anxiety and panic disorders, has been recalled due to the product’s potential to cause adverse health effects.
U.S. Food and Drug Administration officials announced a voluntary recall of Xanax, also known as alprazolam., distributed by West Virginia-based distributor Viatris Specialty LLC.
Viatris Inc., the distributor’s parent company, did not respond to The Times’ request for comment.
Xanax is one of the most widely prescribed medications by doctors to treat generalized anxiety and panic disorders, but addiction experts say it is considered a highly addictive substance because of its psychodynamic properties that include creating feelings of euphoria, according to a report from the National Library of Medicine.
The medication is generally safe and helpful when used as directed, with its expected effect lasting up to six hours, according to the American Addiction Centers.
Viatris Specialty LLC. voluntarily initiated a recall of its product late last month, according to FDA officials. No illnesses or injuries have been reported in connection with the removed pills.
Why this specific part of Xanax was recalled
Xanax tablets were placed under Class II recall because the product did not meet dissolution specifications, meaning it did not dissolve at a standard rate.
The classification of Xanax tablets means that use or exposure to the product may cause temporary or medically reversible adverse health consequences, according to the FDA.
Details of recalled prescription pills
The product withdrawn is Xanax XR, extended release tablets.
The tablets weigh 3 milligrams and there are 60 tablets per bottle.
The product code information is “Lot #8177156” with an expiration date of February 28, 2027, this information can be found on the pill bottle.
Where the product was sold
Xanax tablets were sold nationwide.
What to do if you have a bottle of recalled Xanax
When a prescription drug is subject to a Class II recall, it is typically removed from retail store shelves, but officials said that unless the FDA or recall company directs otherwise, patients and consumers can continue to use the drug.
Neither the FDA nor Viatris have provided further information on whether to stop using Xanax pills.
FDA officials said if you have any questions or concerns about the recalled product, consult your doctor or pharmacist.
“In some cases, stopping your medication may be more harmful to your health than continuing to take the recalled medication,” the FDA said.
